| Gaurav Saxena, PT | |
|
101 Market Place Blvd, Cartersville, GA 30121-2236 | |
| (470) 210-1164 | |
| (470) 344-1208 |
| Full Name | Gaurav Saxena |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 17 Years |
| Location | 101 Market Place Blvd, Cartersville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164611042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT009222 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Orthopedics, Llc | 4385963172 | 149 |
News Archive
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The Wall Street Journal on Wednesday examined how some employers "are looking to take advantage of the geographical variations in quality and cost of health care within the U.S.," and others are "leveraging deals they've struck with foreign hospitals in order to secure better rates with U.S. hospitals."
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
› Verified 9 days ago
| Provider Name | Orthoatlanta, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851937114 PECOS PAC ID: 3971406885 Enrollment ID: O20040129000005 |
News Archive
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The Wall Street Journal on Wednesday examined how some employers "are looking to take advantage of the geographical variations in quality and cost of health care within the U.S.," and others are "leveraging deals they've struck with foreign hospitals in order to secure better rates with U.S. hospitals."
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
› Verified 9 days ago
| Provider Name | Piedmont Orthopedics, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114317062 PECOS PAC ID: 4385963172 Enrollment ID: O20150429000361 |
News Archive
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The Wall Street Journal on Wednesday examined how some employers "are looking to take advantage of the geographical variations in quality and cost of health care within the U.S.," and others are "leveraging deals they've struck with foreign hospitals in order to secure better rates with U.S. hospitals."
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
› Verified 9 days ago
| Provider Name | Reach Movement Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1942823992 PECOS PAC ID: 5799199154 Enrollment ID: O20210126000465 |
News Archive
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The Wall Street Journal on Wednesday examined how some employers "are looking to take advantage of the geographical variations in quality and cost of health care within the U.S.," and others are "leveraging deals they've struck with foreign hospitals in order to secure better rates with U.S. hospitals."
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gaurav Saxena, PT Po Box 208706, Dallas, TX 75320-8706 Ph: (615) 308-3560 | Gaurav Saxena, PT 101 Market Place Blvd, Cartersville, GA 30121-2236 Ph: (470) 210-1164 |
News Archive
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two Johns Hopkins psychiatrists published in the May 17 issue of the New England Journal of Medicine.
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.
The Wall Street Journal on Wednesday examined how some employers "are looking to take advantage of the geographical variations in quality and cost of health care within the U.S.," and others are "leveraging deals they've struck with foreign hospitals in order to secure better rates with U.S. hospitals."
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Atorvastatin and has launched the product in the U.S. market.
Researchers at the University of Massachusetts Amherst and the University of Massachusetts Medical School are among the scientists at a dozen institutions nationwide that will form the Justice Community Opioid Innovation Network, an ambitious, $155 million effort to improve opioid addiction treatment in criminal justice settings, the National Institutes of Health announced.
› Verified 9 days ago
Ariel Larocca, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Henderson Dr Ste 301, Cartersville, GA 30120 Phone: 678-721-9922 | |
Mr. Igor Oruc, D.P.T Physical Therapist Medicare: Medicare Enrolled Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Anna Gilbert Anello, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Mrs. Elizabeth A Herlihy, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Taylor Mote, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 Market Place Blvd, Cartersville, GA 30121 Phone: 470-210-1164 | |
Daniel G Pernell, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 150 Gentilly Blvd, Cartersville, GA 30120 Phone: 678-719-7000 Fax: 678-719-7003 | |
Pt Solutions Of Acworth Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 650 Henderson Dr, Suite 301, Cartersville, GA 30120 Phone: 678-721-9922 Fax: 670-721-7799 |